Literature DB >> 30150283

Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.

Ruth J Napier1,2, Ellen J Lee1,2, Emily E Vance1,2, Paige E Snow1, Kimberly A Samson1,2, Clare E Dawson1, Amy E Moran3, Peter Stenzel4, Michael P Davey1,2,5, Shimon Sakaguchi6, Holly L Rosenzweig7,2.   

Abstract

Arthritis in a genetically susceptible SKG strain of mice models a theoretical paradigm wherein autoimmune arthritis arises because of interplay between preexisting autoreactive T cells and environmental stimuli. SKG mice have a point mutation in ZAP-70 that results in attenuated TCR signaling, altered thymic selection, and spontaneous production of autoreactive T cells that cause arthritis following exposure to microbial β-glucans. In this study, we identify Nod2, an innate immune receptor, as a critical suppressor of arthritis in SKG mice. SKG mice deficient in Nod2 (Nod2-/-SKG) developed a dramatically exacerbated form of arthritis, which was independent of sex and microbiota, but required the skg mutation in T cells. Worsened arthritis in Nod2-/-SKG mice was accompanied by expansion of Th17 cells, which to some measure coproduced TNF, GM-CSF, and IL-22, along with elevated IL-17A levels within joint synovial fluid. Importantly, neutralization of IL-17A mitigated arthritis in Nod2-/-SKG mice, indicating that Nod2-mediated protection occurs through suppression of the Th17 response. Nod2 deficiency did not alter regulatory T cell development or function. Instead, Nod2 deficiency resulted in an enhanced fundamental ability of SKG CD4+ T cells (from naive mice) to produce increased levels of IL-17 and to passively transfer arthritis to lymphopenic recipients on a single-cell level. These data reveal a previously unconsidered role for T cell-intrinsic Nod2 as an endogenous negative regulator of Th17 responses and arthritogenic T cells. Based on our findings, future studies aimed at understanding a negative regulatory function of Nod2 within autoreactive T cells could provide novel therapeutic strategies for treatment of patients with arthritis.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30150283      PMCID: PMC6143404          DOI: 10.4049/jimmunol.1700507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice.

Authors:  Jane M M Natividad; Valerie Petit; Xianxi Huang; Giada de Palma; Jennifer Jury; Yolanda Sanz; Dana Philpott; Clara L Garcia Rodenas; Kathy D McCoy; Elena F Verdu
Journal:  Inflamm Bowel Dis       Date:  2011-12-11       Impact factor: 5.325

2.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation.

Authors:  Sukumar Saha; Jin Qi; Shiyong Wang; Minhui Wang; Xinna Li; Yun-Gi Kim; Gabriel Núñez; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

3.  Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.

Authors:  Michael P Davey; Tammy M Martin; Stephen R Planck; Jack Lee; David Zamora; James T Rosenbaum
Journal:  Microvasc Res       Date:  2006-01-18       Impact factor: 3.514

4.  Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis.

Authors:  Hye Won Kim; Yong-Jin Kwon; Byung Wook Park; Jason Jungsik Song; Yong-Beom Park; Min Chan Park
Journal:  Clin Exp Rheumatol       Date:  2017-02-24       Impact factor: 4.473

5.  The Bacterial Peptidoglycan-Sensing Molecules NOD1 and NOD2 Promote CD8+ Thymocyte Selection.

Authors:  Marianne M Martinic; Irina Caminschi; Meredith O'Keeffe; Therese C Thinnes; Raelene Grumont; Steve Gerondakis; Dianne B McKay; David Nemazee; Amanda L Gavin
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

6.  The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced Enteropathy.

Authors:  Galliano Zanello; Ashleigh Goethel; Sandrine Rouquier; David Prescott; Susan J Robertson; Charles Maisonneuve; Catherine Streutker; Dana J Philpott; Kenneth Croitoru
Journal:  J Immunol       Date:  2016-05-20       Impact factor: 5.422

7.  Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.

Authors:  H L Rosenzweig; M M Jann; T T Glant; T M Martin; S R Planck; W van Eden; P J S van Kooten; R A Flavell; K S Kobayashi; J T Rosenbaum; M P Davey
Journal:  J Leukoc Biol       Date:  2009-01-07       Impact factor: 4.962

Review 8.  Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.

Authors:  Mathias Chamaillard; Stephen E Girardin; Jérôme Viala; Dana J Philpott
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

9.  T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.

Authors:  Michael H Shaw; Thornik Reimer; Carmen Sánchez-Valdepeñas; Neil Warner; Yun-Gi Kim; Manuel Fresno; Gabriel Nuñez
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

Review 10.  NOD2 and inflammation: current insights.

Authors:  Anna Negroni; Maria Pierdomenico; Salvatore Cucchiara; Laura Stronati
Journal:  J Inflamm Res       Date:  2018-02-12
View more
  3 in total

1.  Impact of the tumor immune microenvironment on the outcome of pancreatic cancer: a retrospective study based on clinical pathological analysis.

Authors:  Hui Huang; Jichun Sun; Zhiqiang Li; Xianlin Zhang; Zheng Li; Hongwei Zhu; Xiao Yu
Journal:  Gland Surg       Date:  2022-02

2.  Protective role of microRNA-23a/b-3p inhibition against osteoarthritis through Gremlin1-depenent activation of TGF-β/smad signaling in chondrocytesa.

Authors:  Xin Lu; Xisheng Weng; Zheng Li; Bo Yang; Jun Qian; Yue Huang
Journal:  Inflammopharmacology       Date:  2022-04-19       Impact factor: 5.093

Review 3.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.